Published in Genomics and Genetics Weekly, June 16th, 2006
Study 1: A study from Germany has reported that recombinant factor XIII (FXIII) reduces severe pleural effusion in children after open-heart surgery.
"Chylous effusions frequently occur after cardiac surgery due to severe damage to the lymphatic system, thus indicating that the insertion of a chest tube may be necessary. FXIII is discussed as being essential for wound healing.
"The aim of this retrospective study was to evaluate whether the application of a single dose of FXIII results in a reduced amount of pleural effusion, leading to an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.